ImageneBio Inc(IMA)

Biotechnology · San Diego, CA

$4.76+0.05 (+1.17%)

Delayed quote: Oct 6, 2026, 12:31 PM EDT

ImageneBio (IMA) EV/EBIT: History & Chart | TGMCharts

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T16:57:09.949Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:57:09.949Z.

Quote observation: 2026-10-06T16:31:24.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 53,632,121
Total debt · period ending 2026-06-30: 1,912,000
Cash · period ending 2026-06-30: 94,677,000
TTM operating income · period ending 2026-06-30: -58,961,000

FMP input reference: 3f3fe5cfad96663d45aee285232b63282d401ce5a2dce1ebe999e7f7af3a8937

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

IMA EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

IMA Competitors' EV/EBIT Ratio

IMA

ImageneBio Inc

Current

Market Cap

$53.63M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs IMA

Market Cap

$53.70M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs IMA

Market Cap

$54.10M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs IMA

Market Cap

$51.91M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs IMA

Market Cap

$51.61M

EV/EBIT Ratio

11.46x

TTM Avg

6.17x

3Y Avg

6.96x

5Y Avg

6.04x

EXOZ

eXoZymes, Inc.

vs IMA

Market Cap

$51.42M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs IMA

Market Cap

$51.38M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs IMA

Market Cap

$51.33M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs IMA

Market Cap

$50.73M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs IMA

Market Cap

$50.66M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
ImageneBio Inc (IMA)	$53.63M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$53.70M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$54.10M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$51.91M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.61M	11.46x	6.17x	6.96x	6.04x
eXoZymes, Inc. (EXOZ)vs ›	$51.42M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$51.38M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$50.73M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$50.66M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

IMA EV/EBIT Ratio Metrics

IMA Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics